Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia (Q50117907)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia |
scientific article |
Statements
1 reference
Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia (English)
1 reference
S B Soumerai
1 reference
D Ross-Degnan
1 reference
T J McLaughlin
1 reference
C S Casteris
1 reference
P Bollini
1 reference
1 September 1994
1 reference
331
1 reference
10
1 reference
650-655
1 reference